New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
08:03 EDTCLSNCelsion announces data supporting development of ThermoDox
Celsion announced that data supporting the development of ThermoDox, its proprietary heat-activated liposomal encapsulation of doxorubicin, plus high intensity focused ultrasound were presented at the International Symposium on Therapeutic Ultrasound. Mark Dewhirst, D.V.M., Ph.D. presented data demonstrating the potential of ThermoDox plus HIFU to maximize drug delivery to the targeted tumor site. Celsion is exploring the potential of ThermoDox in combination with HIFU as a non-invasive treatment for a variety of cancers, including pancreatic cancer, Glioblastoma Multiforme, metastatic liver cancer, and breast cancer.
News For CLSN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CLSN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use